PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank29
3Y CAGR-24.8%
5Y CAGR-21.8%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-24.8%/yr
Annual compound
5Y CAGR
-21.8%/yr
Consistent
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
5 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$104.71M-40.5%
2024$176.08M-22.0%
2023$225.69M-8.3%
2022$246.03M-20.3%
2021$308.56M-14.1%
2020$359.12M+609.6%
2019$-70.47M-52.7%
2018$-46.14M-